These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 1850365)

  • 1. Dopaminergic regulation of aldosterone secretion: assessment in different subtypes of primary aldosteronism and in essential hypertension.
    Veglio F; Pinna G; Rabbia F; Panarelli M; Bisbocci D; Melchio R; Chiandussi L
    J Int Med Res; 1991; 19(1):44-9. PubMed ID: 1850365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Primary dexamethasone-suppressible hyperaldosteronism and hyperprolactinemia].
    Veglio F; Pinna G; Rabbia F; Mulatero P; Chiandussi L
    Minerva Endocrinol; 1992; 17(1):43-6. PubMed ID: 1323053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differing effects of metoclopramide and adrenocorticotropin on plasma aldosterone levels in glucocorticoid-suppressible hyperaldosteronism and other forms of hyperaldosteronism.
    Ganguly A; Pratt JH; Weinberger MH; Grim CE; Fineberg NS
    J Clin Endocrinol Metab; 1983 Aug; 57(2):388-92. PubMed ID: 6306041
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
    Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
    Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine reduces aldosterone and 18-hydroxycorticosterone response to angiotensin II in patients with essential low-renin hypertension and idiopathic hyperaldosteronism.
    Witzgall H; Lorenz R; von Werder K; Weber PC
    Clin Sci (Lond); 1985 Mar; 68(3):291-9. PubMed ID: 3882312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Concentration of adrenocorticotrophic hormone and aldosterone secretion in essential hypertension and hyperaldosteronism].
    Shkhvatsabaia IK; Pershakova LP; Ustinova SE; Chikhladze NM; Uchitel' IA
    Kardiologiia; 1985 Jan; 25(1):16-22. PubMed ID: 2984449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous dopaminergic inhibition of aldosterone and prolactin secretion is apparently not increased in primary aldosteronism.
    Jungmann E; Althoff PH; Rosak C; Schwedes U; Schöffling K
    Horm Metab Res; 1986 Feb; 18(2):138-40. PubMed ID: 3699687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunoreactive endogenous ouabain in primary aldosteronism and essential hypertension: relationship with plasma renin, aldosterone and blood pressure levels.
    Rossi G; Manunta P; Hamlyn JM; Pavan E; De Toni R; Semplicini A; Pessina AC
    J Hypertens; 1995 Oct; 13(10):1181-91. PubMed ID: 8586810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of endogenous dopamine on mineralocorticoids secretion in normal subjects, patients with primary aldosteronism, and idiopathic hyperaldosteronism].
    Shimizu Y
    Nihon Naibunpi Gakkai Zasshi; 1984 Jan; 60(1):1-15. PubMed ID: 6745468
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative diagnosis and localization of aldosterone-producing adenoma by adrenal venous sampling after administration of metoclopramide.
    Wu KD; Liao TS; Chen YM; Lai MK; Chen SJ; Su CT; Chu TS; Chang CC; Hsieh BS
    J Formos Med Assoc; 2001 Sep; 100(9):598-603. PubMed ID: 11695274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of naloxone on the adrenal cortex in primary aldosteronism.
    Fallo F; Boscaro M; Sonino N; Mantero F
    Am J Hypertens; 1988 Jul; 1(3 Pt 1):280-2. PubMed ID: 2839206
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The long-term administration of dexamethasone for the differentiation of the 4 types of hyperaldosteronism].
    Watanabe Y; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1995 Mar; 71(2):149-66. PubMed ID: 7750627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of metoclopramide, a dopamine inhibitor, on aldosterone secretion in patients with primary aldosteronism].
    Mizuno K; Yaginuma K; Yamazaki M; Fukuchi S
    Nihon Naibunpi Gakkai Zasshi; 1982 Aug; 58(8):976-83. PubMed ID: 6292008
    [No Abstract]   [Full Text] [Related]  

  • 18. [Influence of endogenous renin-angiotensin system on plasma aldosterone responsiveness to metoclopramide].
    Iwasaki Y
    Nihon Naibunpi Gakkai Zasshi; 1987 Feb; 63(2):123-32. PubMed ID: 3032700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence for endogenous dopaminergic control of mineralocorticoids secretion in normal subjects and in patients with hyperaldosteronism.
    Shimizu Y; Hanew K; Sato S; Sasaki A; Murakami O; Yoshinaga K
    Tohoku J Exp Med; 1984 Sep; 144(1):33-42. PubMed ID: 6506061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overproduction of sodium-retaining steroids by the zona glomerulosa is adrenocorticotropin-dependent and mediates hypertension in dexamethasone-suppressible aldosteronism.
    Gill JR; Bartter FC
    J Clin Endocrinol Metab; 1981 Aug; 53(2):331-7. PubMed ID: 6265487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.